Corrigendum to “MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC” [Biomed. Pharmacother. 110 (2019) 656–666]

oleh: Jing Quan, Xiang Pan, Yawen Li, Yimin Hu, Lingzhi Tao, Zuwei Li, Liwen Zhao, Jingyao Wang, Hang Li, Yulin Lai, Liang Zhou, Canbin Lin, Yaoting Gui, Jing Ye, Fangting Zhang, Yongqing Lai